Zanubrutinib
- Product NameZanubrutinib
- CAS1691249-45-2
- CBNumberCB93361383
- MFC27H29N5O3
- MW471.55
- EINECS-0
- MDL NumberMFCD31567461
- MOL File1691249-45-2.mol
Chemical Properties
Boiling point | 713.4±60.0 °C(Predicted) |
Density | 1.33±0.1 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO:99.67(Max Conc. mg/mL);211.36(Max Conc. mM) DMF:10.0(Max Conc. mg/mL);21.21(Max Conc. mM) DMF:PBS (pH 7.2) (1:5):0.16(Max Conc. mg/mL);0.34(Max Conc. mM) Ethanol:33.33(Max Conc. mg/mL);70.68(Max Conc. mM) |
form | A solid |
pka | 15.35±0.40(Predicted) |
NCI Dictionary of Cancer Terms | zanubrutinib |
FDA UNII | AG9MHG098Z |
NCI Drug Dictionary | zanubrutinib |
ATC code | L01EL03 |
Safety
Symbol(GHS) | ||||||||||
Signal word | Warning | |||||||||
Hazard statements | H302-H315-H319-H335 | |||||||||
Precautionary statements | P261-P305+P351+P338 | |||||||||
NFPA 704: |
|